BofA lowered the firm’s price target on Thermo Fisher (TMO) to $660 from $675 and keeps a Buy rating on the shares. The Life Sciences Tools sector underperformed again in FY24 as Pharma and Biotech ...

Thermo Fisher Scientific Inc. (NYSE:TMO) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 15, ...

Evercore ISI analyst Vijay Kumar raised the firm’s price target on Thermo Fisher (TMO) to $650 from $610 and keeps an Outperform rating on the ...

Wells Fargo raised the firm’s price target on Thermo Fisher (TMO) to $680 from $660 and keeps an Overweight rating on the shares. Core growth is steadily improving quarter-over-quarter and 2025 ...

BofA lowered the firm’s price target on Thermo Fisher (TMO) to $545 from $680 and keeps a Buy rating on the shares. Sentiment for Life Sciences and Diagnostic Tools and Contract Research Organizations ...

Thermo Fisher Scientific stock has reached a 52-week high, hitting $610.97. This milestone reflects a robust performance over the past year, with the stock experiencing a notable 1-year change of ...

Barclays analyst Luke Sergott lowered the firm’s price target on Thermo Fisher (TMO) to $610 from $620 and keeps an Equal Weight rating on the shares after the company reported an in-line quarter ...

Investing.com - KeyBanc upgraded Thermo Fisher Scientific (NYSE:TMO) from Sector Weight to Overweight on Monday, setting a price target of $750.00. The target represents approximately 31% upside from ...